25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

XINT (Xintela) Stock Analysis
Buy, Hold or Sell?

Let's analyze Xintela together

I guess you are interested in Xintela AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Xintela’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Xintela’s Price Targets

I'm going to help you getting a better view of Xintela AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Xintela AB

I send you an email if I find something interesting about Xintela AB.

1. Quick Overview

1.1. Quick analysis of Xintela (30 sec.)










1.2. What can you expect buying and holding a share of Xintela? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr-0.03
Expected worth in 1 year
kr-0.04
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
kr-0.01
Return On Investment
-3.2%

For what price can you sell your share?

Current Price per Share
kr0.41
Expected price per share
kr0.292 - kr0.526
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Xintela (5 min.)




Live pricePrice per Share (EOD)
kr0.41
Intrinsic Value Per Share
kr-0.62 - kr-0.59
Total Value Per Share
kr-0.65 - kr-0.61

2.2. Growth of Xintela (5 min.)




Is Xintela growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.7m-$620.7k-$1.1m-64.6%

How much money is Xintela making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$1.2m$280.2k27.5%
Net Profit Margin-64,607.2%-4,670.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Xintela (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#781 / 881

Most Revenue
#555 / 881

Most Profit
#242 / 881

Most Efficient
#870 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Xintela?

Welcome investor! Xintela's management wants to use your money to grow the business. In return you get a share of Xintela.

First you should know what it really means to hold a share of Xintela. And how you can make/lose money.

Speculation

The Price per Share of Xintela is kr0.414. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Xintela.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Xintela, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr-0.03. Based on the TTM, the Book Value Change Per Share is kr0.00 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Xintela.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.00-0.4%0.00-0.4%0.00-0.5%0.00-0.5%0.00-0.5%0.00-0.4%
Usd Book Value Change Per Share0.00-0.4%0.00-0.1%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.4%0.00-0.1%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Price Per Share0.04-0.04-0.03-0.04-0.09-0.15-
Price to Earnings Ratio-6.45--6.74--4.07--4.87--12.11--37.56-
Price-to-Total Gains Ratio-25.15--18.88--17.02--10.02--19.48--75.63-
Price to Book Ratio-16.16--19.14-6.74--9.51-40.68-152.78-
Price-to-Total Gains Ratio-25.15--18.88--17.02--10.02--19.48--75.63-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.043677
Number of shares22895
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (22895 shares)-8.11-3.35
Gains per Year (22895 shares)-32.44-13.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-32-420-13-23
20-65-740-27-36
30-97-1060-40-49
40-130-1380-54-62
50-162-1700-67-75
60-195-2020-80-88
70-227-2340-94-101
80-260-2660-107-114
90-292-2980-120-127
100-324-3300-134-140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.041.00.00.0%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%13.024.03.032.5%13.024.04.031.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.041.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%13.024.03.032.5%13.024.04.031.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Xintela AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.016-0.003-79%0.001-1601%0.000-98%-0.001-91%-0.001-96%
Book Value Per Share---0.025-0.0250%-0.009-65%-0.016-35%0.000-14449%0.012-306%
Current Ratio--0.4160.435-4%0.907-54%0.613-32%1.184-65%2.848-85%
Debt To Asset Ratio--2.2812.608-13%1.438+59%1.968+16%1.446+58%0.864+164%
Debt To Equity Ratio----0%1.166-100%0.659-100%1.369-100%1.695-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--239343404.928225867550.672+6%168397747.456+42%205340539.008+17%554258386.374-57%1050800612.608-77%
Eps---0.016-0.015-7%-0.018+18%-0.019+23%-0.020+30%-0.015-5%
Ev To Sales Ratio--427.3992798.793-85%359.898+19%1985.828-78%1985.828-78%114426.821-100%
Free Cash Flow Per Share---0.015-0.013-17%-0.017+9%-0.014-7%-0.014-8%-0.011-25%
Free Cash Flow To Equity Per Share---0.015-0.002-90%0.003-658%0.010-259%0.009-265%0.005-402%
Gross Profit Margin--1.0001.066-6%1.103-9%1.081-8%1.081-8%1.123-11%
Intrinsic Value_10Y_max---0.587----------
Intrinsic Value_10Y_min---0.622----------
Intrinsic Value_1Y_max---0.048----------
Intrinsic Value_1Y_min---0.058----------
Intrinsic Value_3Y_max---0.152----------
Intrinsic Value_3Y_min---0.180----------
Intrinsic Value_5Y_max---0.267----------
Intrinsic Value_5Y_min---0.305----------
Market Cap275640378.624+2%268982404.928252004550.672+7%185424747.456+45%227591955.675+18%570139486.374-53%976883816.662-72%
Net Profit Margin---74.479-646.072+767%-46.701-37%-230.924+210%-138.555+86%-701.320+842%
Operating Margin----652.5210%-48.0650%-233.5290%-140.1170%-698.1100%
Operating Ratio--73.100671.736-89%50.675+44%240.804-70%144.482-49%696.563-90%
Pb Ratio-16.560-2%-16.160-19.138+18%6.736-340%-9.514-41%40.684-140%152.784-111%
Pe Ratio-6.609-2%-6.449-6.744+5%-4.065-37%-4.869-24%-12.113+88%-37.558+482%
Price Per Share0.414+2%0.4040.379+7%0.279+45%0.342+18%0.856-53%1.467-72%
Price To Free Cash Flow Ratio-6.747-2%-6.58418.222-136%-2.833-57%3.041-316%1.971-434%-134.674+1946%
Price To Total Gains Ratio-25.773-2%-25.150-18.883-25%-17.016-32%-10.024-60%-19.480-23%-75.633+201%
Quick Ratio--0.0060.227-97%0.699-99%0.470-99%1.058-99%2.646-100%
Return On Assets---0.802-0.781-3%-0.711-11%-0.891+11%-0.732-9%-0.500-38%
Return On Equity----0%-0.9100%-0.5400%-0.9650%-0.9350%
Total Gains Per Share---0.016-0.003-79%0.001-1601%0.000-98%-0.001-91%-0.001-96%
Usd Book Value---1756047.500-1751194.5000%-620709.250-65%-1148446.625-35%12238.000-14449%851200.375-306%
Usd Book Value Change Per Share---0.0020.000-79%0.000-1601%0.000-98%0.000-91%0.000-96%
Usd Book Value Per Share---0.003-0.0030%-0.001-65%-0.002-35%0.000-14449%0.001-306%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--25250729.22023829026.596+6%17765962.357+42%21663426.865+17%58474259.762-57%110859464.630-77%
Usd Eps---0.002-0.002-7%-0.002+18%-0.002+23%-0.002+30%-0.002-5%
Usd Free Cash Flow---1077577.000-889576.000-17%-1172896.250+9%-1003867.667-7%-991320.200-8%-806945.763-25%
Usd Free Cash Flow Per Share---0.002-0.001-17%-0.002+9%-0.002-7%-0.001-8%-0.001-25%
Usd Free Cash Flow To Equity Per Share---0.0020.000-90%0.000-658%0.001-259%0.001-265%0.001-402%
Usd Market Cap29080059.945+2%28377643.72026586480.096+7%19562310.857+45%24010951.324+18%60149715.812-53%103061242.658-72%
Usd Price Per Share0.044+2%0.0430.040+7%0.029+45%0.036+18%0.090-53%0.155-72%
Usd Profit---1100048.500-1018549.750-7%-1298757.750+18%-1386656.833+26%-1453969.350+32%-1051703.125-4%
Usd Revenue--14770.000106977.000-86%9943.375+49%38973.458-62%23384.075-37%17882.250-17%
Usd Total Gains Per Share---0.0020.000-79%0.000-1601%0.000-98%0.000-91%0.000-96%
 EOD+6 -2MRQTTM+9 -25YOY+17 -183Y+15 -205Y+9 -2610Y+6 -29

3.3 Fundamental Score

Let's check the fundamental score of Xintela AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.609
Price to Book Ratio (EOD)Between0-1-16.560
Net Profit Margin (MRQ)Greater than0-74.479
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.006
Current Ratio (MRQ)Greater than10.416
Debt to Asset Ratio (MRQ)Less than12.281
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.802
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Xintela AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.612
Ma 20Greater thanMa 500.439
Ma 50Greater thanMa 1000.420
Ma 100Greater thanMa 2000.417
OpenGreater thanClose0.398
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Xintela AB

Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company's stem cell products include XSTEM, which is in Phase I/IIa clinical development for the treatment of knee osteoarthritis, as well as in clinical study for the treatment of difficult-to-heal leg ulcers, acute respiratory distress syndrome, and other indications; and EQSTEM that is in preclinical development for the treatment of joint disease in horses. It is also developing antibody-based cancer therapies, such as TARG9 and TARG10, which are in preclinical study for the treatment of triple-negative breast cancer and the brain tumor glioblastoma. It has an agreement with Region Γ–stergΓΆtland for GMP process development of cell therapy for burn patients. Xintela AB (publ) was incorporated in 2009 and is based in Lund, Sweden.

Fundamental data was last updated by Penke on 2025-06-11 14:29:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Xintela earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compareΒ Xintela to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -7,447.9%Β means thatΒ kr-74.48 for each kr1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Xintela AB:

  • The MRQ is -7,447.9%. The company is making a huge loss. -2
  • The TTM is -64,607.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7,447.9%TTM-64,607.2%+57,159.3%
TTM-64,607.2%YOY-4,670.1%-59,937.1%
TTM-64,607.2%5Y-13,855.5%-50,751.7%
5Y-13,855.5%10Y-70,132.0%+56,276.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,447.9%-88.2%-7,359.7%
TTM-64,607.2%-141.5%-64,465.7%
YOY-4,670.1%-182.9%-4,487.2%
3Y-23,092.4%-247.7%-22,844.7%
5Y-13,855.5%-338.6%-13,516.9%
10Y-70,132.0%-473.1%-69,658.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Xintela is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Xintela to theΒ Biotechnology industry mean.
  • -80.2% Return on Assets means thatΒ Xintela generatedΒ kr-0.80 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Xintela AB:

  • The MRQ is -80.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -78.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-80.2%TTM-78.1%-2.1%
TTM-78.1%YOY-71.1%-7.0%
TTM-78.1%5Y-73.2%-4.9%
5Y-73.2%10Y-50.0%-23.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-80.2%-11.1%-69.1%
TTM-78.1%-11.2%-66.9%
YOY-71.1%-11.0%-60.1%
3Y-89.1%-11.6%-77.5%
5Y-73.2%-11.8%-61.4%
10Y-50.0%-13.6%-36.4%
4.3.1.3. Return on Equity

Shows how efficient Xintela is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Xintela to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Xintela generated kr0.00Β for eachΒ kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Xintela AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-91.0%+91.0%
TTM-5Y-96.5%+96.5%
5Y-96.5%10Y-93.5%-3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.8%+12.8%
TTM--14.2%+14.2%
YOY-91.0%-14.1%-76.9%
3Y-54.0%-16.6%-37.4%
5Y-96.5%-17.3%-79.2%
10Y-93.5%-19.4%-74.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Xintela AB.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Xintela is operatingΒ .

  • Measures how much profit Xintela makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Xintela to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated kr0.00 Β for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Xintela AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-65,252.1%+65,252.1%
TTM-65,252.1%YOY-4,806.5%-60,445.7%
TTM-65,252.1%5Y-14,011.7%-51,240.4%
5Y-14,011.7%10Y-69,811.0%+55,799.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--227.4%+227.4%
TTM-65,252.1%-253.9%-64,998.2%
YOY-4,806.5%-201.7%-4,604.8%
3Y-23,352.9%-214.9%-23,138.0%
5Y-14,011.7%-339.9%-13,671.8%
10Y-69,811.0%-444.7%-69,366.3%
4.3.2.2. Operating Ratio

Measures how efficient Xintela is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 73.10 means that the operating costs are kr73.10 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Xintela AB:

  • The MRQ is 73.100. The company is inefficient in keeping operating costs low. -1
  • The TTM is 671.736. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ73.100TTM671.736-598.636
TTM671.736YOY50.675+621.061
TTM671.7365Y144.482+527.254
5Y144.48210Y696.563-552.081
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ73.1002.060+71.040
TTM671.7362.737+668.999
YOY50.6752.997+47.678
3Y240.8043.496+237.308
5Y144.4824.660+139.822
10Y696.5636.353+690.210
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Xintela AB.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Xintela is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.42Β means the company has kr0.42 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Xintela AB:

  • The MRQ is 0.416. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.435. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.416TTM0.435-0.020
TTM0.435YOY0.907-0.471
TTM0.4355Y1.184-0.748
5Y1.18410Y2.848-1.664
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4163.670-3.254
TTM0.4353.745-3.310
YOY0.9074.121-3.214
3Y0.6134.623-4.010
5Y1.1845.733-4.549
10Y2.8486.143-3.295
4.4.3.2. Quick Ratio

Measures if Xintela is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Xintela to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.01Β means the company can pay off kr0.01 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Xintela AB:

  • The MRQ is 0.006. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.227. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.006TTM0.227-0.221
TTM0.227YOY0.699-0.473
TTM0.2275Y1.058-0.831
5Y1.05810Y2.646-1.588
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0062.906-2.900
TTM0.2273.128-2.901
YOY0.6993.786-3.087
3Y0.4704.308-3.838
5Y1.0585.703-4.645
10Y2.6466.411-3.765
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Xintela AB.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of XintelaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Xintela to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.28Β means that Xintela assets areΒ financed with 228.1% credit (debt) and the remaining percentage (100% - 228.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Xintela AB:

  • The MRQ is 2.281. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.608. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.281TTM2.608-0.327
TTM2.608YOY1.438+1.171
TTM2.6085Y1.446+1.162
5Y1.44610Y0.864+0.582
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2810.328+1.953
TTM2.6080.356+2.252
YOY1.4380.335+1.103
3Y1.9680.339+1.629
5Y1.4460.350+1.096
10Y0.8640.383+0.481
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Xintela is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Xintela to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has kr0.00 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Xintela AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.166-1.166
TTM-5Y1.369-1.369
5Y1.36910Y1.695-0.326
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.384-0.384
TTM-0.436-0.436
YOY1.1660.413+0.753
3Y0.6590.447+0.212
5Y1.3690.464+0.905
10Y1.6950.512+1.183
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every kr1 in earnings Xintela generates.

  • Above 15 is considered overpriced butΒ always compareΒ Xintela to theΒ Biotechnology industry mean.
  • A PE ratio of -6.45 means the investor is paying kr-6.45Β for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Xintela AB:

  • The EOD is -6.609. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.449. Based on the earnings, the company is expensive. -2
  • The TTM is -6.744. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.609MRQ-6.449-0.160
MRQ-6.449TTM-6.744+0.295
TTM-6.744YOY-4.065-2.678
TTM-6.7445Y-12.113+5.369
5Y-12.11310Y-37.558+25.445
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.609-2.125-4.484
MRQ-6.449-2.027-4.422
TTM-6.744-2.541-4.203
YOY-4.065-3.670-0.395
3Y-4.869-3.716-1.153
5Y-12.113-6.057-6.056
10Y-37.558-6.591-30.967
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Xintela AB:

  • The EOD is -6.747. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.584. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 18.222. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-6.747MRQ-6.584-0.163
MRQ-6.584TTM18.222-24.806
TTM18.222YOY-2.833+21.056
TTM18.2225Y1.971+16.252
5Y1.97110Y-134.674+136.645
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.747-3.030-3.717
MRQ-6.584-2.710-3.874
TTM18.222-3.805+22.027
YOY-2.833-4.404+1.571
3Y3.041-5.103+8.144
5Y1.971-8.536+10.507
10Y-134.674-9.228-125.446
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Xintela is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -16.16 means the investor is paying kr-16.16Β for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Xintela AB:

  • The EOD is -16.560. Based on the equity, the company is expensive. -2
  • The MRQ is -16.160. Based on the equity, the company is expensive. -2
  • The TTM is -19.138. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.560MRQ-16.160-0.400
MRQ-16.160TTM-19.138+2.978
TTM-19.138YOY6.736-25.874
TTM-19.1385Y40.684-59.822
5Y40.68410Y152.784-112.100
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.5601.900-18.460
MRQ-16.1601.861-18.021
TTM-19.1382.162-21.300
YOY6.7362.465+4.271
3Y-9.5142.527-12.041
5Y40.6843.682+37.002
10Y152.7844.351+148.433
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets12,994
Total Liabilities29,639
Total Stockholder Equity-16,645
 As reported
Total Liabilities 29,639
Total Stockholder Equity+ -16,645
Total Assets = 12,994

Assets

Total Assets12,994
Total Current Assets12,326
Long-term Assets669
Total Current Assets
Cash And Cash Equivalents 6,398
Net Receivables 175
Other Current Assets 1
Total Current Assets  (as reported)12,326
Total Current Assets  (calculated)6,574
+/- 5,752
Long-term Assets
Property Plant Equipment 669
Long-term Assets  (as reported)669
Long-term Assets  (calculated)669
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities29,640
Long-term Liabilities-1
Total Stockholder Equity-16,645
Total Current Liabilities
Accounts payable 3,123
Other Current Liabilities 23,103
Total Current Liabilities  (as reported)29,640
Total Current Liabilities  (calculated)26,226
+/- 3,414
Long-term Liabilities
Long-term Liabilities  (as reported)-1
Long-term Liabilities  (calculated)0
+/- 1
Total Stockholder Equity
Total Stockholder Equity (as reported)-16,645
Total Stockholder Equity (calculated)0
+/- 16,645
Other
Capital Stock19,974
Common Stock Shares Outstanding 665,798
Net Invested Capital -16,645
Net Working Capital -17,314



6.2. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
> Total Assets 
0
0
0
10,622
0
30,905
26,857
23,849
27,350
22,811
17,946
28,585
21,984
21,686
19,205
49,714
39,398
29,745
21,048
17,093
21,087
30,799
36,171
48,513
34,744
50,512
39,513
24,742
16,022
11,750
12,268
24,517
16,905
13,991
20,722
18,395
22,084
10,933
7,890
24,798
12,994
12,99424,7987,89010,93322,08418,39520,72213,99116,90524,51712,26811,75016,02224,74239,51350,51234,74448,51336,17130,79921,08717,09321,04829,74539,39849,71419,20521,68621,98428,58517,94622,81127,35023,84926,85730,905010,622000
   > Total Current Assets 
824
0
0
6,531
5,523
27,492
23,636
19,589
23,148
18,310
12,516
22,923
14,088
9,773
4,204
34,039
24,005
14,531
5,830
3,015
7,838
8,121
24,279
37,675
24,609
40,684
30,585
16,127
7,393
4,362
6,009
19,301
12,624
10,645
18,224
16,843
20,743
9,806
6,961
24,013
12,326
12,32624,0136,9619,80620,74316,84318,22410,64512,62419,3016,0094,3627,39316,12730,58540,68424,60937,67524,2798,1217,8383,0155,83014,53124,00534,0394,2049,77314,08822,92312,51618,31023,14819,58923,63627,4925,5236,53100824
       Cash And Cash Equivalents 
-824
0
0
5,523
-5,523
26,562
23,027
18,979
22,476
17,691
11,919
21,910
12,531
8,197
2,838
31,397
20,994
11,328
2,685
412
359
764
13,029
33,601
15,503
6,426
15,894
9,941
2,304
142
878
8,343
2,415
697
11,703
7,809
10,409
445
1,338
16,680
6,398
6,39816,6801,33844510,4097,80911,7036972,4158,3438781422,3049,94115,8946,42615,50333,60113,0297643594122,68511,32820,99431,3972,8388,19712,53121,91011,91917,69122,47618,97923,02726,562-5,5235,52300-824
       Short-term Investments 
1,648
0
0
0
11,046
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000011,0460001,648
       Net Receivables 
0
0
0
277
0
0
0
0
0
0
0
0
197
0
0
0
0
0
0
1,997
6,067
6,265
10,824
3,476
7,936
33,574
14,007
-1,233
4,956
4,123
5,045
10,640
9,396
8,749
5,656
97
7,490
6,719
907
1,361
175
1751,3619076,7197,490975,6568,7499,39610,6405,0454,1234,956-1,23314,00733,5747,9363,47610,8246,2656,0671,99700000019700000000277000
       Other Current Assets 
0
0
0
731
0
930
609
610
672
619
597
1,013
1,360
1,576
1,366
2,642
3,011
3,203
3,145
2,603
7,479
7,357
11,250
4,074
9,106
34,258
14,691
5,516
5,089
4,220
5,131
1,138
10,209
9,948
6,521
8,937
10,334
9,361
5,024
5,972
1
15,9725,0249,36110,3348,9376,5219,94810,2091,1385,1314,2205,0895,51614,69134,2589,1064,07411,2507,3577,4792,6033,1453,2033,0112,6421,3661,5761,3601,0135976196726106099300731000
   > Long-term Assets 
-824
0
0
4,091
-5,523
3,413
3,221
4,260
4,202
4,501
5,430
5,662
7,896
11,913
15,001
15,675
15,393
15,214
15,218
14,077
13,249
22,678
11,892
10,838
10,134
9,828
8,929
8,615
8,628
7,387
6,258
5,216
4,280
3,346
2,498
1,552
1,341
1,127
929
785
669
6697859291,1271,3411,5522,4983,3464,2805,2166,2587,3878,6288,6158,9299,82810,13410,83811,89222,67813,24914,07715,21815,21415,39315,67515,00111,9137,8965,6625,4304,5014,2024,2603,2213,413-5,5234,09100-824
       Property Plant Equipment 
0
0
0
278
0
435
402
482
450
475
890
828
3,046
6,907
10,287
12,871
12,880
12,840
13,147
11,516
10,838
10,122
9,768
8,877
8,263
8,046
7,236
7,012
7,270
6,144
5,307
4,575
3,752
2,929
2,192
1,358
1,215
1,072
929
785
669
6697859291,0721,2151,3582,1922,9293,7524,5755,3076,1447,2707,0127,2368,0468,2638,8779,76810,12210,83811,51613,14712,84012,88012,87110,2876,9073,0468288904754504824024350278000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,242
950
0
527
417
0
0
0
0
0
0
0
000000041752709501,24200000000000000000000000000000
       Intangible Assets 
0
0
0
3,812
0
2,978
2,819
3,778
3,752
4,026
4,540
4,834
4,850
5,006
4,664
2,754
2,463
2,173
1,882
1,597
1,460
1,324
1,187
1,050
974
898
822
746
1,354
1
1
640
1
0
306
195
125
56
0
0
0
0005612519530601640111,3547468228989741,0501,1871,3241,4601,5971,8822,1732,4632,7544,6645,0064,8504,8344,5404,0263,7523,7782,8192,97803,812000
       Long-term Assets Other 
-824
0
0
1
-5,523
0
0
0
0
0
0
0
0
0
100
100
100
402
378
1,928
951
11,232
1,874
911
897
884
871
857
4
0
0
1
0
0
0
-1
1
-1
0
2
0
020-11-100010048578718848979111,87411,2329511,928378402100100100000000000-5,523100-824
> Total Liabilities 
0
0
0
3,161
0
2,261
1,237
2,866
1,714
2,215
2,234
10,170
11,396
16,471
18,371
4,769
3,914
4,921
4,184
7,769
19,283
28,324
19,073
20,906
7,588
12,015
8,924
20,795
30,442
45,059
14,882
18,740
27,458
42,608
12,317
14,015
29,786
29,062
33,562
30,748
29,639
29,63930,74833,56229,06229,78614,01512,31742,60827,45818,74014,88245,05930,44220,7958,92412,0157,58820,90619,07328,32419,2837,7694,1844,9213,9144,76918,37116,47111,39610,1702,2342,2151,7142,8661,2372,26103,161000
   > Total Current Liabilities 
0
0
0
3,161
0
2,261
1,238
2,866
1,714
2,215
2,234
10,170
11,396
16,471
18,371
4,769
3,914
4,921
4,184
7,770
19,283
17,425
8,172
20,907
7,588
12,015
8,924
20,795
30,442
45,059
14,882
18,740
27,458
42,608
12,317
14,015
29,786
29,062
33,561
30,748
29,640
29,64030,74833,56129,06229,78614,01512,31742,60827,45818,74014,88245,05930,44220,7958,92412,0157,58820,9078,17217,42519,2837,7704,1844,9213,9144,76918,37116,47111,39610,1702,2342,2151,7142,8661,2382,26103,161000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,000
0
10,900
2,808
3,175
2,971
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000002,9713,1752,80810,90008,000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,000
0
10,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000010,90008,000000000000000000000000
       Accounts payable 
0
0
0
1,791
0
1,438
648
1,234
808
1,111
1,269
1,891
2,659
3,460
4,951
2,738
1,674
2,473
2,208
3,785
5,505
5,252
3,709
2,712
3,097
5,648
3,793
3,899
7,096
14,057
8,063
8,846
10,224
8,400
4,988
7,483
5,271
4,828
5,318
2,837
3,123
3,1232,8375,3184,8285,2717,4834,9888,40010,2248,8468,06314,0577,0963,8993,7935,6483,0972,7123,7095,2525,5053,7852,2082,4731,6742,7384,9513,4602,6591,8911,2691,1118081,2346481,43801,791000
       Other Current Liabilities 
0
0
0
1,215
0
742
460
1,527
783
949
849
8,062
8,515
12,784
13,191
1,718
2,116
2,164
1,666
3,611
13,653
4,158
4,463
7,062
4,491
6,367
5,131
16,761
23,137
30,659
6,451
9,495
16,994
33,996
7,329
6,448
24,515
24,234
28,243
27,911
23,103
23,10327,91128,24324,23424,5156,4487,32933,99616,9949,4956,45130,65923,13716,7615,1316,3674,4917,0624,4634,15813,6533,6111,6662,1642,1161,71813,19112,7848,5158,0628499497831,52746074201,215000
   > Long-term Liabilities 
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
10,899
10,901
-1
0
0
0
3,899
7,096
14,057
8,063
8,846
10,224
0
0
0
0
0
1
0
-1
-1010000010,2248,8468,06314,0577,0963,899000-110,90110,8990-1000000000000-1000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000010,9000000000000000000000000
> Total Stockholder Equity
3,887
0
0
7,461
7,461
28,644
25,620
20,983
25,636
20,596
15,712
18,415
10,588
5,215
834
44,945
35,484
24,824
16,864
9,324
1,804
2,475
17,098
27,607
27,156
38,497
30,589
3,947
-14,420
-33,309
-2,614
5,777
-10,553
-28,617
8,405
4,380
-7,702
-18,129
-25,672
-5,950
-16,645
-16,645-5,950-25,672-18,129-7,7024,3808,405-28,617-10,5535,777-2,614-33,309-14,4203,94730,58938,49727,15627,60717,0982,4751,8049,32416,86424,82435,48444,9458345,21510,58818,41515,71220,59625,63620,98325,62028,6447,4617,461003,887
   Common Stock
0
0
0
536
0
746
746
746
810
810
810
911
911
911
911
1,184
1,184
1,184
1,184
1,184
1,224
1,224
1,726
2,219
2,315
2,636
2,674
2,674
2,674
2,674
9,227
9,227
9,227
9,227
16,377
17,010
17,010
17,063
17,063
19,974
0
019,97417,06317,06317,01017,01016,3779,2279,2279,2279,2272,6742,6742,6742,6742,6362,3152,2191,7261,2241,2241,1841,1841,1841,1841,1849119119119118108108107467467460536000
   Retained Earnings Total Equity00000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
3,887
0
0
0
7,461
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
39
0
128
1
0
85
57
29
-4
-259,808
-278,697
-293,361
393
-94
243
185
1,289
204
-734
0
555
0
05550-7342041,289185243-94393-293,361-278,697-259,808-429578501128039000000000000-107,4610003,887
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
140,889
140,889
150,518
173,084
208,435
216,935
239,752
242,714
242,714
242,714
242,714
281,520
305,920
305,920
305,920
0
0
0
0
0
0
0
0000000305,920305,920305,920281,520242,714242,714242,714242,714239,752216,935208,435173,084150,518140,889140,8890000000000000000000
   Treasury Stock00000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
29,905
0
63,467
63,467
61,646
71,276
71,252
71,252
82,264
82,395
82,678
82,265
133,505
133,445
133,385
133,325
141,174
141,085
150,818
172,938
208,548
216,934
239,752
242,714
242,710
502,827
521,808
575,250
305,920
305,920
306,163
343,987
349,927
349,927
350,376
349,895
376,557
0
0376,557349,895350,376349,927349,927343,987306,163305,920305,920575,250521,808502,827242,710242,714239,752216,934208,548172,938150,818141,085141,174133,325133,385133,445133,50582,26582,67882,39582,26471,25271,25271,27661,64663,46763,467029,905000



6.3. Balance Sheets

Currency in SEK. All numbers in thousands.




6.4. Cash Flows

Currency in SEK. All numbers in thousands.




6.5. Income Statements

Currency in SEK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue4,215
Cost of Revenue-552
Gross Profit3,6633,663
 
Operating Income (+$)
Gross Profit3,663
Operating Expense-43,662
Operating Income-39,447-39,999
 
Operating Expense (+$)
Research Development33,221
Selling General Administrative7,178
Selling And Marketing Expenses3,263
Operating Expense43,66243,662
 
Net Interest Income (+$)
Interest Income26
Interest Expense-2,113
Other Finance Cost-0
Net Interest Income-2,087
 
Pretax Income (+$)
Operating Income-39,447
Net Interest Income-2,087
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-41,534-37,360
EBIT - interestExpense = -41,560
-41,534
-37,077
Interest Expense2,113
Earnings Before Interest and Taxes (EBIT)-39,447-39,421
Earnings Before Interest and Taxes (EBITDA)-38,895
 
After tax Income (+$)
Income Before Tax-41,534
Tax Provision--2,344
Net Income From Continuing Ops-39,190-39,190
Net Income-39,190
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses43,662
Total Other Income/Expenses Net-2,0872,087
 

Technical Analysis of Xintela
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Xintela. The general trend of Xintela is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Xintela's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Xintela Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Xintela AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.41 < 0.52 < 0.526.

The bearish price targets are: 0.36 > 0.315 > 0.292.

Know someone who trades $XINT? Share this with them.πŸ‘‡

Xintela AB Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Xintela AB. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Xintela AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Xintela AB. The current macd is -0.0007153.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Xintela price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Xintela. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Xintela price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Xintela AB Daily Moving Average Convergence/Divergence (MACD) ChartXintela AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Xintela AB. The current adx is 21.62.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Xintela shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Xintela AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Xintela AB. The current sar is 0.51068418.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Xintela AB Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Xintela AB. The current rsi is 45.61. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Xintela AB Daily Relative Strength Index (RSI) ChartXintela AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Xintela AB. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Xintela price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Xintela AB Daily Stochastic Oscillator ChartXintela AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Xintela AB. The current cci is -105.8972733.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Xintela AB Daily Commodity Channel Index (CCI) ChartXintela AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Xintela AB. The current cmo is -16.19143581.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Xintela AB Daily Chande Momentum Oscillator (CMO) ChartXintela AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Xintela AB. The current willr is -66.25.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Xintela is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Xintela AB Daily Williams %R ChartXintela AB Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Xintela AB.

Xintela AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Xintela AB. The current atr is 0.04736977.

Xintela AB Daily Average True Range (ATR) ChartXintela AB Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Xintela AB. The current obv is 7,510,009.

Xintela AB Daily On-Balance Volume (OBV) ChartXintela AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Xintela AB. The current mfi is 24.02.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Xintela AB Daily Money Flow Index (MFI) ChartXintela AB Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Xintela AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Xintela AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Xintela AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.612
Ma 20Greater thanMa 500.439
Ma 50Greater thanMa 1000.420
Ma 100Greater thanMa 2000.417
OpenGreater thanClose0.398
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Xintela with someone you think should read this too:
  • Are you bullish or bearish on Xintela? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Xintela? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Xintela AB

I send you an email if I find something interesting about Xintela AB.


Comments

How you think about this?

Leave a comment

Stay informed about Xintela AB.

Receive notifications about Xintela AB in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.